S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.16%) $0.928
USD/NOK
(0.16%) $10.86
USD/GBP
(-0.01%) $0.792
USD/RUB
(-0.03%) $92.55

Realtime updates for CSL Ltd [CSL.AX]

Exchange: ASX Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated28 Mar 2024 @ 01:10

0.55% $ 287.92

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 01:10):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally...

Stats
Today's Volume 634 725
Average Volume 692 469
Market Cap 139.14B
EPS $0 ( 2024-02-13 )
Last Dividend $1.621 ( 2023-03-09 )
Next Dividend $0 ( N/A )
P/E 37.06
ATR14 $0.0990 (0.03%)

Volume Correlation

Long: 0.12 (neutral)
Short: 0.90 (very strong)
Signal:(46.94) Expect same movement, but be aware

CSL Ltd Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CSL Ltd Correlation - Currency/Commodity

The country flag -0.54
( weak negative )
The country flag -0.70
( moderate negative )
The country flag 0.00
( neutral )
The country flag 0.11
( neutral )
The country flag -0.49
( neutral )
The country flag 0.07
( neutral )

CSL Ltd Financials

Annual 2023
Revenue: $19.59B
Gross Profit: $9.47B (48.33 %)
EPS: $6.92
Q2 2023
Revenue: $12.28B
Gross Profit: $6.30B (51.29 %)
EPS: $6.01
Q4 2023
Revenue: $8.91B
Gross Profit: $3.96B (44.45 %)
EPS: $1.850
Q3 2022
Revenue: $4.58B
Gross Profit: $2.23B (48.65 %)
EPS: $0.880

Financial Reports:

No articles found.

CSL Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$1.758
(N/A)
$0
(N/A)
$1.621
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

CSL Ltd Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.24 - Increase likely (44.85%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0167 1994-11-08
Last Dividend $1.621 2023-03-09
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 59 --
Total Paid Out $28.07 --
Avg. Dividend % Per Year 0.00% --
Score 4.48 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 7.24
Div. Directional Score 9.63 --
Next Divdend (Est)
(2024-06-24)
$0 Estimate 3.73 %
Dividend Stability
0.30 Very Poor
Dividend Score
4.48
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Warning: Undefined variable $stockPricesArray in /home/getagraph/public_html/stock.php on line 1111

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for ASX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
TNE.AX Ex Dividend Knight 2023-06-01 Semi-Annually 0 0.00%
D2O.AX Ex Dividend Junior 2023-10-12 Semi-Annually 0 0.00%
NUF.AX Ex Dividend Junior 2023-05-25 Annually 0 0.00%
ACQ.AX Ex Dividend Knight 2023-11-09 Semi-Annually 0 0.00%
FPH.AX Ex Dividend Knight 2023-06-26 Semi-Annually 0 0.00%
PRU.AX Ex Dividend Knight 2023-09-12 Semi-Annually 0 0.00%
AZJ.AX Ex Dividend Junior 2023-08-28 Semi-Annually 0 0.00%
ILU.AX Ex Dividend Knight 2023-09-01 Annually 0 0.00%
SFC.AX Ex Dividend Knight 2023-09-07 Semi-Annually 0 0.00%
CEN.AX Ex Dividend Junior 2023-09-07 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1801.5006.419.61[0 - 0.5]
returnOnAssetsTTM0.06961.2007.689.21[0 - 0.3]
returnOnEquityTTM0.1561.5009.3810.00[0.1 - 1]
payoutRatioTTM0.450-1.0005.50-5.50[0 - 1]
currentRatioTTM2.150.8004.253.40[1 - 3]
quickRatioTTM0.9710.8009.007.20[0.8 - 2.5]
cashRatioTTM0.2161.5009.9110.00[0.2 - 2]
debtRatioTTM0.282-1.5005.30-7.95[0 - 0.6]
interestCoverageTTM6.971.0008.538.53[3 - 30]
operatingCashFlowPerShareTTM8.342.007.2210.00[0 - 30]
freeCashFlowPerShareTTM3.592.008.2110.00[0 - 20]
debtEquityRatioTTM0.612-1.5007.55-10.00[0 - 2.5]
grossProfitMarginTTM0.4841.0005.265.26[0.2 - 0.8]
operatingProfitMarginTTM0.2441.0007.127.12[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2611.0009.669.66[0.2 - 2]
assetTurnoverTTM0.3880.800-0.748-0.599[0.5 - 2]
Total Score12.02

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM36.511.0006.410[1 - 100]
returnOnEquityTTM0.1562.509.6010.00[0.1 - 1.5]
freeCashFlowPerShareTTM3.592.008.8010.00[0 - 30]
dividendYielPercentageTTM1.3221.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM8.342.007.2210.00[0 - 30]
payoutRatioTTM0.4501.5005.50-5.50[0 - 1]
pegRatioTTM8.351.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1901.0007.750[0.1 - 0.5]
Total Score7.24

CSL Ltd

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators